Status:
COMPLETED
Sleep, Glycemic Control, and Insulin Resistance in Adolescents With Type 1 Diabetes
Lead Sponsor:
University of Colorado, Denver
Collaborating Sponsors:
Juvenile Diabetes Research Foundation
Colorado Clinical & Translational Sciences Institute
Conditions:
Type1diabetes
Adolescent Behavior
Eligibility:
All Genders
14-19 years
Brief Summary
Despite advancements in care, most adolescents with T1D have higher BMI and significantly higher HbA1c than recommended and are markedly IR, placing them at increased risk for CVD1,2. Thus, alternativ...
Eligibility Criteria
Inclusion
- attending high school
- diagnosis of type 1 diabetes \>1 year
Exclusion
- current diagnosis of a sleep disorder (e.g., insomnia, OSA) or abnormal scores on sleep disorders screening measures
- regular use of medications affecting sleep (e.g., stimulants, atypical antipsychotics, melatonin, other sleep aids)
- HbA1c ≥11 or \>14% for the previous 2+ measurements
- IQ\<70 or severe mental illness
Key Trial Info
Start Date :
December 4 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2023
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT03832790
Start Date
December 4 2019
End Date
June 30 2023
Last Update
October 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Colorado Anschutz Medical Campus/Children's Hospital Colorado
Aurora, Colorado, United States, 80045